Blauvelt, A, B Strober, R Langley, S Kavanagh, C Arendt, M Boehnlein, M Lebwohl, and K Reich. “Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled 96-Week Data from Three Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT)”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S39. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/766.